TuHURA Biosciences, Inc.
NASDAQTuHURA Biosciences enters its May 22 earnings event in an uncomfortable position: the stock is down 27% over the past month to $2.31, short sellers hold nearly a quarter of the free float, and the borrow market has been volatile enough to punish anyone slow to cover. Short interest is the dominant tension here. At 23.9% of the free float — using ORTEX's free-float-adjusted…
Snapshot as of 16 May 2026
TuHURA Biosciences enters its May 22 earnings event in an uncomfortable position: the stock is down 27% over the past month to $2.31, short sellers hold nearly a quarter of the free float, and the borrow market has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HURA — free to start on ORTEX.
Sign up for free →Open HURA on ORTEX